Moderna to Report Third Quarter 2025 Financial Results on Thursday, November 6, 2025
-
Alonso says Verstappen is capable of grabbing sensational fifth title
-
Trump critic John Bolton indicted
-
Trump announces plan aimed at improving IVF accessibility
-
Turkish experts to help find bodies in Gaza, as Trump warns Hamas
-
US stocks fall as regional bank angst adds to list of worries
-
Airbnb and Booking.com accused in France over Israeli settlement listings
-
Hamilton dismisses Horner speculation as a 'distraction'
-
Spain's BBVA fails in Sabadell takeover bid
-
Sainz stands by criticism of TV coverage at Singapore GP
-
Trump says to meet Putin in Budapest after 'great' call
-
Europe 'well positioned' for future shocks: ECB's Lagarde
-
BBVA's Sabadell takeover bid fails: Spanish regulator
-
United States GP declared a heat hazard event
-
'Battlefield' video game sees big-time sales
-
US budget deficit narrows just slightly despite tariff revenues
-
Canterbury Cathedral graffiti exhibition asks questions of God
-
Maccabi Tel Aviv fans cannot attend Europa League Villa match
-
'Wonder weapon'? Five things about US Tomahawks coveted by Ukraine
-
Afghans return home to rubble, hoping truce holds with Pakistan
-
Waymo robotaxis to deliver orders for some US DoorDash users
-
Trump says to meet Putin in Budapest after 'great progress' in call
-
Three reported dead as Kenyan forces fire on mourners for politician Odinga
-
Madagascar's new military leader insists takeover 'not a coup'
-
'Bigger, hotter, faster': extreme blazes drive rise in CO2 fire emissions
-
Leverkusen went in 'wrong direction' under ex-boss Ten Hag, says sporting director
-
China defends Russian oil purchases, slams US 'bullying'
-
Paris auctioneers unveil Renoir child portrait of filmmaker son
-
Johnson & Johnson faces UK lawsuit over talc cancer claim
-
Goalkeeper Pickford signs new Everton contract
-
Trump speaks with Putin ahead of Zelensky visit
-
Infectious diseases 'spiralling out of control' in Gaza: WHO
-
Thinness is back on catwalks -- and the data proves it
-
Stocks higher as traders weigh China-US row, tech earnings
-
Oscar Wilde grandson to collect reissued British Library pass
-
Turkish experts to help find hostage bodies in Gaza
-
Athletes' parade at Winter Olympics' opening ceremony to be held across event sites
-
Billionaire Ronaldo tops Forbes footballer rich list again
-
Kenya security forces fire on mourners for politician Odinga
-
Abuse victims still face 'disturbing' retaliation: Vatican commission
-
Capuozzo back for Italy's November Tests
-
US Fed chair contender backs October rate cut
-
Trump to speak with Putin ahead of Zelensky visit
-
In the doghouse: flying canines count as cargo, EU court rules
-
'Deadly poison': Ageing fertiliser factory stifles Tunisian town
-
Armani names executive close to designer as new CEO
-
Record high 60 million viewers for Women's World Cup
-
After two years of uncertainty, Israeli parents bury hostage son
-
Afghanistan-Pakistan ceasefire holds after deadly border clashes
-
Former boxing world champion Hatton found hanged at home, inquest told
-
Police say Cambodia will deport 59 South Koreans linked to scam centres
NYSE - LSE
Moderna to Report Third Quarter 2025 Financial Results on Thursday, November 6, 2025
CAMBRIDGE, MA, MA / ACCESS Newswire / October 16, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Thursday, November 6, 2025 to report its third quarter 2025 financial results, and provide a corporate update.
A live webcast of the call will be available under "Events and Presentations" in the Investors section of the Moderna website.
Webcast: https://investors.modernatx.com
The archived webcast will be available on Moderna's website approximately two hours after the conference call and will be available for one year following the call.
About Moderna
Moderna is a leader in the creation of the field of mRNA medicine. Through the advancement of mRNA technology, Moderna is reimagining how medicines are made and transforming how we treat and prevent disease for everyone. By working at the intersection of science, technology and health for more than a decade, the company has developed medicines at unprecedented speed and efficiency, including one of the earliest and most effective COVID-19 vaccines.
Moderna's mRNA platform has enabled the development of therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and autoimmune diseases. With a unique culture and a global team driven by the Moderna values and mindsets to responsibly change the future of human health, Moderna strives to deliver the greatest possible impact to people through mRNA medicines. For more information about Moderna, please visit modernatx.com and connect with us on X (formerly Twitter), Facebook, Instagram, YouTube and LinkedIn.
Media Contacts
Investors:
Lavina Talukdar
Senior Vice President & Head of Investor Relations
617-209-5834
[email protected]
SOURCE: Moderna, Inc.
View the original press release on ACCESS Newswire
P.Mathewson--AMWN